{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:41:29Z","timestamp":1787020889097,"version":"build-2736575974"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T00:00:00Z","timestamp":1655337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T00:00:00Z","timestamp":1655337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008257","name":"Tarbiat Modares University","doi-asserted-by":"publisher","award":["Med\/8288"],"award-info":[{"award-number":["Med\/8288"]}],"id":[{"id":"10.13039\/501100008257","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Leishmaniasis is a neglected infectious disease caused by protozoa of the genus\n                      <jats:italic>Leishmania<\/jats:italic>\n                      . The disease generally manifests as characteristic skin lesions which require lengthy treatment with antimonial drugs that are often associated with adverse side effects. Therefore, a number of studies have focused on natural compounds as promising drugs for its treatment. This study aimed to evaluate the effects of larval excretion\/secretion products (ES) of\n                      <jats:italic>Lucilia sericata<\/jats:italic>\n                      in crude and fractionated forms on\n                      <jats:italic>Leishmania major<\/jats:italic>\n                      , by using in vitro and in vivo models.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The in vitro experiments involved evaluation of ES on both promastigotes and macrophage-engulfed amastigotes, whereas the in vivo experiments included comparative treatments of skin lesions in\n                      <jats:italic>L. major<\/jats:italic>\n                      -infected mice with Eucerin-formulated ES and Glucantime.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The half maximal inhibitory concentrations of the crude ES, &gt;\u00a010-kDa ES fraction, &lt;\u00a010-kDa ES fraction, and Glucantime were 38.7\u00a0\u03bcg\/ml, 47.6\u00a0\u03bcg\/ml, 63.3\u00a0\u03bcg\/ml, and 29.1\u00a0\u03bcg\/ml, respectively. Significant differences were observed between percentage viabilities of promastigotes treated with the crude ES and its fractions compared with the negative control (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.0001). The crude ES was more effective on amastigotes than the two ES fractions at 300\u00a0\u03bcg\/ml. The macroscopic measurements revealed that the reduction of lesion size in mice treated with the crude ES followed quicker cascades of healing than that of mice treated with Glucantime and the ES fractions.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      The present study showed that the larval ES of\n                      <jats:italic>L. sericata<\/jats:italic>\n                      in both crude and fractionated forms are effective for both intracellular and extracellular forms of\n                      <jats:italic>L. major<\/jats:italic>\n                      . Also, the ES exert both topical and systemic effects on mice experimentally infected with\n                      <jats:italic>L. major<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s13071-022-05322-7","type":"journal-article","created":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T09:05:52Z","timestamp":1655370352000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Therapeutic effects of Lucilia sericata larval excretion\/secretion products on Leishmania major under in vitro and in vivo conditions"],"prefix":"10.1186","volume":"15","author":[{"given":"Jila","family":"Sherafati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Saaid","family":"Dayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Ghaffarifar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,16]]},"reference":[{"key":"5322_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0004349","volume":"10","author":"M Akhoundi","year":"2016","unstructured":"Akhoundi M, Kuhls K, Cannet A, Vot\u00fdpka J, Marty P, Delaunay P, et al. A historical overview of the classification, evolution, and dispersion of Leishmania parasites and sand flies. PLoS Negl Trop Dis. 2016;10:e0004349.","journal-title":"PLoS Negl Trop Dis"},{"key":"5322_CR2","doi-asserted-by":"publisher","first-page":"90","DOI":"10.2174\/1872214809666150921111956","volume":"9","author":"JF Barbosa","year":"2015","unstructured":"Barbosa JF, de Figueiredo SM, Monteiro FM, Rocha-Silva F, Gaciele-Melo C, Coelho SSC, et al. New approaches on leishmaniasis treatment and prevention: a review of recent patents. Recent Pat Endocr Metab Immune Drug Discov. 2015;9:90\u2013102.","journal-title":"Recent Pat Endocr Metab Immune Drug Discov"},{"key":"5322_CR3","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0035-9203(01)90223-8","volume":"95","author":"P Desjeux","year":"2001","unstructured":"Desjeux P. The increase in risk factors for leishmaniasis worldwide. Trans R Soc Trop Med Hyg. 2001;95:239\u201343.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"5322_CR4","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/s13071-017-2175-8","volume":"10","author":"G Herrera","year":"2017","unstructured":"Herrera G, Hern\u00e1ndez C, Ayala MS, Fl\u00f3rez C, Teher\u00e1n AA, Ram\u00edrez JD. Evaluation of a multilocus sequence typing (MLST) scheme for Leishmania (Viannia) braziliensis and Leishmania (Viannia) panamensis in Colombia. Parasit Vectors. 2017;10:236.","journal-title":"Parasit Vectors"},{"key":"5322_CR5","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1007\/s40265-013-0132-1","volume":"73","author":"B Monge-Maillo","year":"2013","unstructured":"Monge-Maillo B, L\u00f3pez-V\u00e9lez R. Therapeutic options for Old World cutaneous leishmaniasis and New World cutaneous and mucocutaneous leishmaniasis. Drugs. 2013;73:1889\u2013920.","journal-title":"Drugs"},{"key":"5322_CR6","first-page":"93","volume":"53","author":"S Khademvatan","year":"2017","unstructured":"Khademvatan S, Salmanzadeh S, Foroutan-Rad M, Bigdeli S, Hedayati-Rad F, Saki J, et al. Spatial distribution and epidemiological features of cutaneous leishmaniasis in southwest of Iran. Alex J Med. 2017;53:93\u20138.","journal-title":"Alex J Med"},{"key":"5322_CR7","unstructured":"WHO. Control of the leishmaniases: key facts. 2020. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/leishmaniasis. Accessed 17 June 2020."},{"key":"5322_CR8","first-page":"36","volume":"46","author":"A Fazaeli","year":"2009","unstructured":"Fazaeli A, Fouladi B, Sharifi I. Emergence of cutaneous leishmaniasis in a border area at south-east of Iran: an epidemiological survey. J Vector Borne Dis. 2009;46:36\u201342.","journal-title":"J Vector Borne Dis"},{"key":"5322_CR9","first-page":"647","volume":"57","author":"M Khajedaluee","year":"2014","unstructured":"Khajedaluee M, Yazdanpanah MJ, Seyed Nozadi S, Fata A, Juya MR, Masoudi MH, et al. Epidemiology of cutaneous leishmaniasis in population covered by Mashhad University of Medical Sciences in 2011. Med J Mashhad Univ Med Sci. 2014;57:647\u201354.","journal-title":"Med J Mashhad Univ Med Sci"},{"key":"5322_CR10","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ijwd.2016.04.003","volume":"2","author":"MA Al-Kamel","year":"2016","unstructured":"Al-Kamel MA. Impact of leishmaniasis in women: a practical review with an update on my ISD-supported initiative to combat leishmaniasis in Yemen (ELYP). Int J Women Dermatol. 2016;2:93\u2013101.","journal-title":"Int J Women Dermatol"},{"key":"5322_CR11","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/S1995-7645(12)60084-4","volume":"5","author":"N Singh","year":"2012","unstructured":"Singh N, Kumar M, Singh RK. Leishmaniasis: current status of available drugs and new potential drug targets. Asian Pac J Trop Med. 2012;5:485\u201397.","journal-title":"Asian Pac J Trop Med"},{"key":"5322_CR12","doi-asserted-by":"publisher","first-page":"e525","DOI":"10.1016\/j.ijid.2011.03.021","volume":"15","author":"TS Tiuman","year":"2011","unstructured":"Tiuman TS, Santos AO, Ueda-Nakamura T, Dias Filho BP, Nakamura CV. Recent advances in leishmaniasis treatment. Int J Infect Dis. 2011;15:e525\u201332.","journal-title":"Int J Infect Dis"},{"key":"5322_CR13","doi-asserted-by":"publisher","first-page":"638957","DOI":"10.3389\/fmicb.2021.638957","volume":"12","author":"M Bamorovat","year":"2021","unstructured":"Bamorovat M, Sharifi I, Tavakoli Oliaee R, Jafarzadeh A, Khosravi A. Determinants of unresponsiveness to treatment in cutaneous leishmaniasis: a focus on anthroponotic form due to Leishmania tropica. Front Microbiol. 2021;12:638957. https:\/\/doi.org\/10.3389\/fmicb.2021.638957.","journal-title":"Front Microbiol"},{"key":"5322_CR14","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.drup.2004.07.002","volume":"7","author":"M Ouellette","year":"2004","unstructured":"Ouellette M, Drummelsmith J, Papadopoulou B. Leishmaniasis: drugs in the clinic, resistance and new developments. Drug Resist Updat. 2004;7:257\u201366.","journal-title":"Drug Resist Updat"},{"key":"5322_CR15","doi-asserted-by":"publisher","first-page":"227","DOI":"10.5114\/ada.2019.82827","volume":"36","author":"M Omidian","year":"2019","unstructured":"Omidian M, Jadbabaei M, Omidian E, Omidian Z. The effect of Nd:YAG laser therapy on cutaneous leishmaniasis compared to intralesional meglumine antimoniate. Postepy Dermatol Alergol. 2019;36:227\u201331.","journal-title":"Postepy Dermatol Alergol"},{"key":"5322_CR16","doi-asserted-by":"publisher","first-page":"107847","DOI":"10.1016\/j.exppara.2020.107847","volume":"210","author":"CG Mac\u00eado","year":"2020","unstructured":"Mac\u00eado CG, Fonseca MYN, Caldeira AD, Castro SP, Pacienza-Lima W, Borsodi MPG, et al. Leishmanicidal activity of Piper marginatum Jacq. from Santar\u00e9m-PA against Leishmania amazonensis. Exp Parasitol. 2020;210:107847.","journal-title":"Exp Parasitol"},{"key":"5322_CR17","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/592419","author":"RA Sherman","year":"2014","unstructured":"Sherman RA. Mechanisms of maggot-induced wound healing: what do we know, and where do we go from here? Evid Based Complement Alternat Med. 2014. https:\/\/doi.org\/10.1155\/2014\/592419.","journal-title":"Evid Based Complement Alternat Med"},{"key":"5322_CR18","doi-asserted-by":"publisher","first-page":"446","DOI":"10.2337\/diacare.26.2.446","volume":"26","author":"RA Sherman","year":"2003","unstructured":"Sherman RA. Maggot therapy for treating diabetic foot ulcers unresponsive to conventional therapy. Diabetes Care. 2003;26:446\u201351.","journal-title":"Diabetes Care"},{"key":"5322_CR19","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1742-481X.2011.00919.x","volume":"9","author":"K Zarchi","year":"2012","unstructured":"Zarchi K, Jemec GB. The efficacy of maggot debridement therapy\u2013a review of comparative clinical trials. Int Wound J. 2012;9:469\u201377.","journal-title":"Int Wound J"},{"key":"5322_CR20","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1177\/014107680009300206","volume":"93","author":"M Courtenay","year":"2000","unstructured":"Courtenay M, Church J, Ryan T. Larva therapy in wound management. J R Soc Med. 2000;93:72\u20134.","journal-title":"J R Soc Med"},{"key":"5322_CR21","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/00004630-200021030-00012","volume":"21","author":"N Namias","year":"2000","unstructured":"Namias N, Varela EJ, Varas RP, Quintana O, Ward GC. Biodebridement: a case report of maggot therapy for limb salvage after fourth-degree burns. J Burn Care Res. 2000;21:254\u20137.","journal-title":"J Burn Care Res"},{"key":"5322_CR22","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1046\/j.1365-2133.2003.04935.x","volume":"148","author":"L Chambers","year":"2003","unstructured":"Chambers L, Woodrow S, Brown A, Harris P, Phillips D, Hall M, et al. Degradation of extracellular matrix components by defined proteinases from the greenbottle larva Lucilia sericata used for the clinical debridement of non-healing wounds. Br J Dermatol Suppl. 2003;148:14\u201323.","journal-title":"Br J Dermatol Suppl"},{"key":"5322_CR23","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jab.2014.01.001","volume":"12","author":"I Valachova","year":"2014","unstructured":"Valachova I, Majtan T, Takac P, Majtan J. Identification and characterisation of different proteases in Lucilia sericata medicinal maggots involved in maggot debridement therapy. J Appl Biomed. 2014;12:171\u20137.","journal-title":"J Appl Biomed"},{"key":"5322_CR24","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1046\/j.1524-475X.2002.10403.x","volume":"10","author":"RA Sherman","year":"2002","unstructured":"Sherman RA. Maggot versus conservative debridement therapy for the treatment of pressure ulcers. Wound Repair Regen. 2002;10:208\u201314.","journal-title":"Wound Repair Regen"},{"key":"5322_CR25","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1053\/apmr.2001.24300","volume":"82","author":"RA Sherman","year":"2001","unstructured":"Sherman RA, Sherman J, Gilead L, Lipo M, Mumcuoglu KY. Maggot debridement therapy in outpatients. Arch Phys Med Rehabil. 2001;82:1226\u20139.","journal-title":"Arch Phys Med Rehabil"},{"key":"5322_CR26","doi-asserted-by":"publisher","first-page":"e0135093","DOI":"10.1371\/journal.pone.0135093","volume":"10","author":"A Baumann","year":"2015","unstructured":"Baumann A, Lehmann R, Beckert A, Vilcinskas A, Franta Z. Selection and evaluation of tissue specific reference genes in Lucilia sericata during an immune challenge. PLoS ONE. 2015;10:e0135093.","journal-title":"PLoS ONE"},{"key":"5322_CR27","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.micinf.2007.12.011","volume":"10","author":"A Bexfield","year":"2008","unstructured":"Bexfield A, Bond AE, Roberts EC, Dudley E, Nigam Y, Thomas S, et al. The antibacterial activity against MRSA strains and other bacteria of a < 500 Da fraction from maggot excretions\/secretions of Lucilia sericata (Diptera: Calliphoridae). Microbes Infect. 2008;10:325\u201333.","journal-title":"Microbes Infect"},{"key":"5322_CR28","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.exppara.2012.06.004","volume":"132","author":"E Polat","year":"2012","unstructured":"Polat E, Cakan H, Aslan M, Sirekbasan S, Kutlubay Z, Ipek T, et al. Detection of anti-leishmanial effect of the Lucilia sericata larval secretions in vitro and in vivo on Leishmania tropica: first work. Exp Parasitol. 2012;132:129\u201334.","journal-title":"Exp Parasitol"},{"key":"5322_CR29","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.exppara.2016.08.007","volume":"170","author":"A Sanei-Dehkordi","year":"2016","unstructured":"Sanei-Dehkordi A, Khamesipour A, Akbarzadeh K, Akhavan AA, Mohammadi AMA, Mohammadi Y, et al. Anti Leishmania activity of Lucilia sericata and Calliphora vicina maggots in laboratory models. Exp Parasitol. 2016;170:59\u201365.","journal-title":"Exp Parasitol"},{"key":"5322_CR30","first-page":"403","volume-title":"House-flies, blow-flies and their allies (Calyptratae: Diptera)","author":"R Crosskey","year":"1993","unstructured":"Crosskey R, Lane R. House-flies, blow-flies and their allies (Calyptratae: Diptera). Medical insects and arachnids: Springer; 1993. p. 403\u201328."},{"key":"5322_CR31","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3897\/zookeys.420.7645","volume":"420","author":"KA Williams","year":"2014","unstructured":"Williams KA, Villet MH. Morphological identification of Lucilia sericata, Lucilia cuprina and their hybrids (Diptera: Calliphoridae). ZooKeys. 2014;420:69\u201385.","journal-title":"ZooKeys"},{"key":"5322_CR32","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/mve.12232","volume":"31","author":"N Gasz","year":"2017","unstructured":"Gasz N, Harvey M. A new method for the production of sterile colonies of Lucilia sericata. Med Vet Entomol. 2017;31:299\u2013305.","journal-title":"Med Vet Entomol"},{"key":"5322_CR33","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.actatropica.2016.09.020","volume":"164","author":"L Cruz-Saavedra","year":"2016","unstructured":"Cruz-Saavedra L, D\u00edaz-Roa A, Gaona MA, Cruz ML, Ayala M, Cort\u00e9s-Vecino JA, et al. The effect of Lucilia sericata- and Sarconesiopsis magellanica-derived larval therapy on Leishmania panamensis. Acta Trop. 2016;164:280\u20139.","journal-title":"Acta Trop"},{"key":"5322_CR34","doi-asserted-by":"publisher","first-page":"137","DOI":"10.12816\/0000271","volume":"6","author":"SM Alnaimat","year":"2013","unstructured":"Alnaimat SM, Wainwright M, Aladaileh SH. An initial in vitro investigation into the potential therapeutic use of Lucilia sericata maggot to control superficial fungal infections. Jordan J Biol Sci. 2013;6:137\u201342.","journal-title":"Jordan J Biol Sci"},{"key":"5322_CR35","doi-asserted-by":"publisher","first-page":"105","DOI":"10.22270\/jddt.v10i1-s.3921","volume":"10","author":"AK Mehata","year":"2020","unstructured":"Mehata AK, Dehari D. Bradford assay as a high-throughput bioanalytical screening method for conforming pathophysiological state of the animal. J Drug Deliv Ther. 2020;10:105\u201310.","journal-title":"J Drug Deliv Ther"},{"key":"5322_CR36","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.ijbiomac.2017.08.177","volume":"107","author":"J Varshosaz","year":"2018","unstructured":"Varshosaz J, Arbabi B, Pestehchian N, Saberi S, Delavari M. Chitosan-titanium dioxide-Glucantime nanoassemblies effects on promastigote and amastigote of Leishmania major. Int J Biol Macromol. 2018;107:212\u201321.","journal-title":"Int J Biol Macromol"},{"key":"5322_CR37","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1080\/13880209.2017.1325380","volume":"55","author":"AR Garcia","year":"2017","unstructured":"Garcia AR, Amaral ACF, Azevedo MM, Corte-Real S, Lopes RC, Alviano CS, et al. Cytotoxicity and anti-Leishmania amazonensis activity of Citrus sinensis leaf extracts. Pharm Biol. 2017;55:1780\u20136.","journal-title":"Pharm Biol"},{"key":"5322_CR38","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.ultsonch.2018.01.022","volume":"43","author":"R Abazari","year":"2018","unstructured":"Abazari R, Mahjoub AR, Molaie S, Ghaffarifar F, Ghasemi E, Slawin AM, et al. The effect of different parameters under ultrasound irradiation for synthesis of new nanostructured Fe3O4@ bio-MOF as an efficient anti-leishmanial in vitro and in vivo conditions. Ultrason Sonochem. 2018;43:248\u201361.","journal-title":"Ultrason Sonochem"},{"key":"5322_CR39","first-page":"576","volume":"15","author":"S Haghdoust","year":"2020","unstructured":"Haghdoust S, Azizi M, Hoseini MHM, Bandehpour M, Masooleh MM, Yeganeh F. Parasite burden measurement in the Leishmania major infected mice by using the direct fluorescent microscopy, limiting dilution assay, and real-time PCR analysis. Iran J Parasitol. 2020;15:576\u201386.","journal-title":"Iran J Parasitol"},{"key":"5322_CR40","first-page":"2028","volume":"18","author":"E Ghasemi","year":"2019","unstructured":"Ghasemi E, Ghaffarifar F, Dalimi A, Sadraei J. In-vitro and in-vivo antileishmanial activity of a compound derived of platinum, oxaliplatin, against Leishmania major. Iran J Pharm Res. 2019;18:2028\u201341.","journal-title":"Iran J Pharm Res"},{"key":"5322_CR41","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s13071-021-04649-x","volume":"14","author":"S Rahimi","year":"2021","unstructured":"Rahimi S, Akhavan AA, Rafinejad J, Ahmadkhaniaha R, Bakhtiyari M, Veysi A, et al. The leishmanicidal effect of Lucilia sericata larval saliva and hemolymph on in vitro Leishmania tropica. Parasit Vectors. 2021;14:155.","journal-title":"Parasit Vectors"},{"key":"5322_CR42","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.1016\/j.ijantimicag.2010.06.023","volume":"36","author":"JAR Postigo","year":"2010","unstructured":"Postigo JAR. Leishmaniasis in the World Health Organization Eastern Mediterranean region. Int J Antimicrob Agents. 2010;36:S62\u20135.","journal-title":"Int J Antimicrob Agents"},{"key":"5322_CR43","first-page":"399","volume":"123","author":"SL Croft","year":"2006","unstructured":"Croft SL, Seifert K, Yardley V. Current scenario of drug development for leishmaniasis. Indian J Med Res. 2006;123:399\u2013410.","journal-title":"Indian J Med Res"},{"key":"5322_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2020.112910","volume":"257","author":"A Karimipoursaryazdi","year":"2020","unstructured":"Karimipoursaryazdi A, Ghaffarifar F, Dalimi A, Dayer MS. In-vitro and in-vivo comparative effects of the spring- and autumn-harvested Artemisia aucheri Bioss extracts on Leishmania major. J Ethnopharmacol. 2020;257:112910.","journal-title":"J Ethnopharmacol"},{"key":"5322_CR45","doi-asserted-by":"publisher","first-page":"177","DOI":"10.5152\/tpd.2014.3410","volume":"38","author":"E Polat","year":"2014","unstructured":"Polat E, Kutlubay Z. Four cutaneous leishmaniosis case resistant to meglumine antimoniate treatment. Turk Parazitolojii Derg. 2014;38:177\u201380.","journal-title":"Turk Parazitolojii Derg"},{"key":"5322_CR46","first-page":"389","volume":"24","author":"M Kabiri","year":"2017","unstructured":"Kabiri M, Dayer MS, Ghaffarifar F. Therapeutic effects of Lucilia sericata larvae on cutaneous leishmaniasis wounds caused by Leishmania major using BALB\/c mice as animal model. J Kerman Univ Med Sci. 2017;24:389\u201396.","journal-title":"J Kerman Univ Med Sci"},{"key":"5322_CR47","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.actatropica.2014.11.003","volume":"142","author":"YT Pinilla","year":"2015","unstructured":"Pinilla YT, Patarroyo MA, Velandia ML, Segura NA, Bello FJ. The effects of Sarconesiopsis magellanica larvae (Diptera: Calliphoridae) excretions and secretions on fibroblasts. Acta Trop. 2015;142:26\u201333.","journal-title":"Acta Trop"},{"key":"5322_CR48","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.actatropica.2017.09.033","volume":"177","author":"MJ Laverde-Paz","year":"2018","unstructured":"Laverde-Paz MJ, Echeverry MC, Patarroyo MA, Bello FJ. Evaluating the anti-Leishmania activity of Lucilia sericata and Sarconesiopsis magellanica blowfly larval excretions\/secretions in an in vitro model. Acta Trop. 2018;177:44\u201350.","journal-title":"Acta Trop"},{"key":"5322_CR49","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.exppara.2013.11.003","volume":"136","author":"TF de Mello","year":"2014","unstructured":"de Mello TF, Bitencourt HR, Pedroso RB, Aristides SM, Lonardoni MV, Silveira TG. Leishmanicidal activity of synthetic chalcones in Leishmania (Viannia) braziliensis. Exp Parasitol. 2014;136:27\u201334.","journal-title":"Exp Parasitol"},{"key":"5322_CR50","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1017\/S000748530999071X","volume":"100","author":"KM Barnes","year":"2010","unstructured":"Barnes KM, Gennard DE, Dixon RA. An assessment of the antibacterial activity in larval excretion\/secretion of four species of insects recorded in association with corpses, using Lucilia sericata Meigen as the marker species. Bull Entomol Res. 2010;100:635\u201340.","journal-title":"Bull Entomol Res"},{"key":"5322_CR51","first-page":"179","volume":"46","author":"MI Hassan","year":"2016","unstructured":"Hassan MI, Amer MS, Hammad KM, Zidan MM. Antimicrobial activity for excretion and secretion of the greenbottle fly larvae Lucilia Sericata (Meigen) (Diptera: Calliphoridae). J Egypt Soc Parasitol. 2016;46:179\u201384.","journal-title":"J Egypt Soc Parasitol"},{"key":"5322_CR52","doi-asserted-by":"publisher","first-page":"123","DOI":"10.12968\/jowc.2007.16.3.27011","volume":"16","author":"L Huberman","year":"2007","unstructured":"Huberman L, Gollop N, Mumcuoglu K, Block C, Galun R. Antibacterial properties of whole body extracts and haemolymph of Lucilia sericata maggots. J Wound Care. 2007;16:123\u20137.","journal-title":"J Wound Care"},{"key":"5322_CR53","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1055\/s-0030-1250663","volume":"77","author":"AG Tempone","year":"2011","unstructured":"Tempone AG, de Oliveira CM, Berlinck RG. Current approaches to discover marine antileishmanial natural products. Planta Med. 2011;77:572\u201385.","journal-title":"Planta Med"},{"key":"5322_CR54","doi-asserted-by":"publisher","first-page":"e8071","DOI":"10.1371\/journal.pone.0008071","volume":"4","author":"MJ van der Plas","year":"2009","unstructured":"van der Plas MJ, van Dissel JT, Nibbering PH. Maggot secretions skew monocyte-macrophage differentiation away from a pro-inflammatory to a pro-angiogenic type. PLoS ONE. 2009;4:e8071.","journal-title":"PLoS ONE"},{"key":"5322_CR55","doi-asserted-by":"publisher","first-page":"305","DOI":"10.7705\/biomedica.v28i2.102","volume":"28","author":"J Arrivillaga","year":"2008","unstructured":"Arrivillaga J, Rodr\u00edguez J, Oviedo M. Evaluaci\u00f3n preliminar en un modelo animal de la terapia con larvas de Lucilia sericata para el tratamiento de la leishmaniasis cut\u00e1nea. Biomedica. 2008;28:305\u201310.","journal-title":"Biomedica"}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-022-05322-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13071-022-05322-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-022-05322-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T10:05:10Z","timestamp":1655373910000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-022-05322-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,16]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["5322"],"URL":"https:\/\/doi.org\/10.1186\/s13071-022-05322-7","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,16]]},"assertion":[{"value":"26 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The experimental animal protocols were conducted according to the guidelines of the Experimental Animal Center of Tarbiat Modares University. The study was approved by the Ethics Committee of Tarbiat Modares University (approval no. IR.MODARES.REC.1399.124).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All of the authors gave their full consent for the publication of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"212"}}